Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/899Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kamila, M M | - |
| dc.contributor.author | Mondal, N | - |
| dc.contributor.author | Ghosh, L K | - |
| dc.date.accessioned | 2008-04-10T05:49:08Z | - |
| dc.date.available | 2008-04-10T05:49:08Z | - |
| dc.date.issued | 2008-03 | - |
| dc.identifier.issn | 0971–457X | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/899 | - |
| dc.description | 194-196 | en_US |
| dc.description.abstract | A simple, sensitive and accurate UV spectrophotometric method has been developed for the determination of eprosartan mesylate in raw material and experimental tablets. Beer’s law was obeyed in the concentration range 2-30 μg mL⁻¹ for the drug (λ = 232 nm) with an apparent molar absorptivity and Sandell sensitivity of 2.8 × 10⁴ L.mol⁻¹cm⁻¹ and 0. 01854 µg cm⁻²/0.001A, respectively. The limits of detection and quantitation were calculated to be 0.3623 and 1.098 µg mL⁻¹, respectively. Results were validated statistically according to ICH guidelines. Validation of the method yielded good results in the concerning range (2-30 µg mL⁻¹), linearity (r² = 0.9998), precision and accuracy. The excipients present in the experimental tablets did not interfere with the method. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | CSIR | en_US |
| dc.source | IJCT Vol.15(2) [March 2008] | en_US |
| dc.subject | Eprosartan mesylate | en_US |
| dc.subject | UV spectrophotometry | en_US |
| dc.title | Spectrophotometric determination of eprosartan mesylate in raw material and experimental tablets | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | IJCT Vol.15(2) [March 2008] | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| IJCT 15(2) (2008) 194-196.pdf | 103.57 kB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.